UK Medical Cannabis Complete Guide

Comprehensive UK Medical Cannabis Guide 2024

Introduction: UK Legal History Since 2018
Medical cannabis became legal in the United Kingdom on 1 November 2018, following a change in the Misuse of Drugs Regulations 1971. This historic decision was prompted by high-profile cases, including that of Billy Caldwell and Alfie Dingley, young children who benefited from cannabis-based medicinal products for severe epilepsy.

Prior to this date, cannabis was classified as a Schedule 1 substance with no recognised medical value. The 2018 reclassification moved cannabis derivatives to Schedule 2, allowing registered doctors to prescribe cannabis-based products to patients where other treatments had failed.

Key Legal Points:

Medical cannabis is prescribed through the NHS or private clinics

Only cannabis-based medicinal products (CBMPs) are legal

Possession without a valid prescription remains illegal

Patients must have exhausted conventional treatments first

Prescription must be issued by a registered medical practitioner

Currently, no products are licensed by the MHRA (Medicines and Healthcare products Regulatory Agency), so all prescriptions are off-licence

Who Qualifies: Full Conditions List with Evidence Levels

Medical cannabis can only be prescribed in the UK for specific conditions where conventional treatments have proven ineffective or inappropriate. The evidence base varies considerably across different conditions.

Condition	Evidence Level	Typical Symptoms Treated	Usually Requires Failed Treatments
Refractory Epilepsy	Strong (Grade A)	Uncontrolled seizures, status epilepticus	2+ anti-epileptic drugs
Multiple Sclerosis (MS)	Moderate (Grade B)	Spasticity, muscle rigidity, pain	Standard MS therapies
Chronic Neuropathic Pain	Moderate (Grade B)	Nerve pain, post-injury pain, chemotherapy neuropathy	Conventional pain management
Cancer-Related Pain	Moderate (Grade B)	Pain, nausea, loss of appetite	Standard oncology treatments
PTSD (Post-Traumatic Stress Disorder)	Emerging (Grade C)	Nightmares, anxiety, hypervigilance	Psychological therapy, SSRIs
Chemotherapy-Induced Nausea/Vomiting	Moderate (Grade B)	Nausea, vomiting, appetite loss	Standard antiemetics
Crohn’s Disease	Emerging (Grade C)	Abdominal pain, inflammation, diarrhoea	Standard IBD treatments
Fibromyalgia	Emerging (Grade C)	Widespread pain, fatigue, sleep disturbance	Standard pain management
Anxiety Disorders	Emerging (Grade C)	Generalised anxiety, panic attacks	SSRIs, psychological therapy
Intractable Migraine	Emerging (Grade C)	Frequent migraines, preventative failure	Prophylactic medications

Important Note on Evidence: Grade A (strong) and Grade B (moderate) evidence conditions are more likely to receive approval. Grade C (emerging) conditions may be considered but require particularly strong clinical justification and documented treatment failures. NHS eligibility is generally limited to refractory epilepsy, MS spasticity, and cancer-related pain.

How to Access Medical Cannabis: Step-by-Step Guide

Step 1: Confirm Your Eligibility

Review the conditions list above and verify that your condition matches qualifying criteria. Gather documentation of previous treatment attempts, including medication names, dosages, duration, and reasons for discontinuation.

Step 2: Choose Your Route

NHS Route (Limited Availability):

Referral typically through specialist consultants only (neurologists, oncologists, gastroenterologists)
GPs cannot directly prescribe on NHS
Most NHS trusts have not implemented prescribing pathways
Waiting times can exceed 12 months in some regions
Currently only refractory epilepsy has established NHS pathways

Private Route (More Accessible):

Direct access without NHS referral requirement
Initial consultation with specialised clinic within 2-4 weeks typically
More flexible condition assessment criteria
Prescription issued privately

Step 3: Select a Clinic

See the clinic comparison table below for major providers. Most charge £100-150 for initial consultations and £50-100 for follow-ups.

Step 4: Initial Consultation

Provide complete medical history
Submit documentation of previous treatments
Attend video or in-person appointment with doctor
Doctor may request additional medical records from your GP
Expect discussion of side effects, drug interactions, and monitoring requirements

Step 5: Treatment Plan Development

If approved, your doctor will:

Select appropriate cannabis product (CBD-dominant, THC-dominant, or balanced)
Determine starting dosage
Establish titration schedule (gradual dose increases)
Set follow-up appointment timescale (typically 2-4 weeks)

Step 6: Prescription and Pharmacy Arrangement

Clinic issues prescription to contracted pharmacy
Pharmacy prepares medication (may require special ordering)
Delivery arranged to your home or clinic collection available
First delivery typically within 5-10 business days

Step 7: Ongoing Monitoring

Regular follow-up appointments every 4-8 weeks initially
Dose adjustments based on therapeutic response and side effects
Periodic blood tests may be required
Annual review appointments standard practice

Clinic Comparison Table

Clinic	Initial Consultation	Follow-up Cost	Speed of Access	Specialties	Product Range
Lyphe Group	£100-150	£70-100	2-3 weeks	Neurological, pain, MS, oncology	10+ products, flower, oils, capsules
Releaf	£125	£75	1-2 weeks	Broad spectrum, including PTSD	8+ products, comprehensive range
Mamedica	£120	£80	2-3 weeks	Pain, anxiety, chronic conditions	6+ products, oils predominantly
Curaleaf	£130	£85	2-4 weeks	Epilepsy, pain, neurological	12+ products, premium range
Sapphire Medical	£140	£90	3-4 weeks	Specialist neurology, epilepsy	7+ products, clinical focus
Dispensary Green	£110	£75	2-3 weeks	Broad spectrum, affordability focus	5+ products, budget-friendly

Costs: Full Breakdown

Cost Component	Typical Range	Notes
Initial Consultation	£100-150	Video or in-person; some clinics offer lower rates for financial hardship
Follow-up Consultation (4-8 weekly)	£50-100	Usually shorter; sometimes included in initial package
Annual Review	£80-120	Comprehensive reassessment required annually
Cannabis Flower (10g)	£50-80	Medical grade; price varies by strain and THC:CBD ratio
Cannabis Oil (10ml bottle)	£40-90	Concentration-dependent; 1000mg-2000mg CBD common
Capsules (30 capsules)	£35-75	Consistent dosing; convenient for travel
Dried Flower Monthly (30g)	£150-240	Typical patient usage; varies with condition severity
Oil Monthly (30ml)	£120-270	Most popular format; includes consultation
Blood Tests (when required)	£50-150	Baseline and annual monitoring; clinic dependent
Pharmacy Handling/Delivery	£10-25	Usually included; charged separately by some pharmacies
Annual Total (typical patient)	£1,200-2,500	Includes consultations, medication, monitoring

Cost-Saving Tips:

Some clinics offer package rates for multiple consultations
Direct cannabis costs often lower than equivalent pharmaceutical alternatives
Charitable organisations provide limited financial assistance
NHS prescriptions (when available) are charged at standard prescription rate (£9.90 in England)
Consider membership schemes offered by some clinics for regular patients

Products Available

Product Types and Formats

Product Type	Typical THC:CBD Ratio	Onset Time	Duration	Best For
Dried Flower (whole plant cannabis)	Variable (1:1 to 20:1)	5-15 minutes (vaporised)	2-4 hours	Pain, nausea, spasticity; flexible dosing
Cannabis Oil (sublingual drops)	Typically CBD or balanced	20-30 minutes	4-8 hours	Anxiety, chronic pain, PTSD; convenient
Capsules (gelatin or vegan)	Consistent dosing (10-20mg typical)	30-60 minutes	6-10 hours	Travel, discretion, consistent dosing
Distillate Syringes	Pure cannabinoids (95%+)	5-30 minutes (route dependent)	2-8 hours	Severe symptoms, high-dose patients
Transdermal Patches	CBD or balanced	Slow release (2-4 hours to peak)	12-24 hours	Constant symptom management, pain
Edibles (chocolates, gummies)	Variable dosing	60-120 minutes	8-12 hours	Palatability, long-lasting relief

Specific Products Available on UK Market (Examples)

Nabilone (Cesamet): Synthetic cannabinoid; oral capsule; primarily for chemotherapy nausea
Sativex (Nabiximols): Oromucosal spray; balanced THC:CBD; primarily for MS spasticity
Adven FL (various strains): Dried flower; THC-dominant varieties; prescribed for pain and spasticity
Bedrocan FLOS: Low-THC, high-CBD flower; neuropathic pain, anxiety
Tilray Products: Range including high-CBD oils, flowers, and capsules
Khiron Products: Full-spectrum oils, flowers, paste formats
Grow Pharma Products: Various formulations including medicinal cannabis flowers

Dosing Overview

Condition	Typical Starting Dose	Typical Maintenance Dose	Titration Approach
Epilepsy (Refractory)	CBD 2-5mg/kg daily	5-20mg/kg daily	Slow titration; increase every 3-5 days
MS Spasticity	2.7mg THC + 2.5mg CBD twice daily (if using Sativex)	5-12 sprays daily (5.4-32.4mg THC:CBD)	Gradual increases; monitor effect
Chronic Pain	5-10mg THC or CBD equivalent	15-30mg daily (divided doses)	Start low, go slow; increase weekly
Anxiety/PTSD	CBD 5-10mg daily	CBD 20-40mg daily	Slow increases; CBD typically without THC
Cancer-Related Nausea	5mg THC as needed	2.5-20mg THC daily or PRN	As-needed dosing initially; stabilise if frequent
Fibromyalgia	Balanced formula 5mg total cannabinoids	10-30mg total cannabinoids daily	Gradual increases; monitor sleep and pain

Dosing Important Notes:

Individual responses vary considerably; personalised titration essential
CBD has a high safety margin; overdose unlikely
THC dosing requires more careful titration to avoid unwanted psychoactive effects
Body weight, metabolism, and previous cannabis exposure affect dosing
Effects may develop over weeks; patience required during titration phase
Maintaining consistent dosing time improves therapeutic outcomes

Patient Rights and Responsibilities

Your Rights as a Medical Cannabis Patient

Right to Information: Full disclosure of potential side effects, contraindications, and drug interactions before starting treatment

Further Reading

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional before starting any new treatment.